Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 45
- Press releases
SOMAÍ Pharmaceuticals Expands to Thailand With New PACCAN Partnership
SOMAÍ Pharmaceuticals, a leading EU-GMP vertically integrated Multi-Country Operator (MCO) with the most advanced cannabinoid pharmaceutical extract portfolio, has partnered with Pacific Cannovation Company Limited (PACCAN) to transform Thailand into a global hub for high-quality medicinal cannabis.
- Uncategorized
New York Cannabis Licence Approvals Hampered as More Lawsuits Stack Up
New York’s adult-use cannabis market continues to be mired in controversy and new legal disputes despite topping $1bn in sales last year.
- Cultivation
What Could Trudeau’s Exit Mean for Cannabis in Canada?
Canada’s Prime Minister, Justin Trudeau, announced last week that he plans to step down as leader of the Liberal Party amid growing internal pressure and falling approval ratings.
- Uncategorized
Cannabis Stocks Fall as DEA Ordered to Respond to Bias Allegations
Cannabis stocks plummeted this week after a judge ordered the Drug Enforcement Agency (DEA) to respond to damning new allegations that it is working to undermine the cannabis rescheduling process.
- Medical
Medical or Recreational? Bedrocan Calls for Stricter Medical Market Regulation From New German Government
The increasingly blurry lines between Germany’s medical and recreational cannabis markets are continuing to cause conflict among lawmakers and industry stakeholders ahead of the upcoming general election.
- Markets & Stocks
Tilray Wins Tender to Supply Luxembourg, Argent Biopharma Completes Capital Raise, & More from Stenocare
Argent BioPharma [stock_market_widget type=”chart” template=”line” assets=”RGT.AX” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Argent Biopharma (previously MGC Pharmaceuticals) has completed a US$4.5 million capital raise to support its drug development efforts, just weeks after delisting from the London Stock Exchange.
- Cultivation
Immediate Investigation into DEA’s Conduct Demanded Ahead of Rescheduling Hearings Amid Fresh Allegations of Bias
The Drug Enforcement Administration (DEA) has come under renewed pressure to be removed from the upcoming cannabis rescheduling process amid fresh allegations of bias.
- Companies
Agrify Sells Cultivation Business, Focuses on THC Beverages with Señorita Brand
Agrify Corporation has completed the sale of its cultivation business to CP Acquisitions LLC, a company affiliated with Agrify’s former CEO, Raymond Chang.
- Uncategorized
Illinois Fails to Pass Bill Regulating Intoxicating Hemp
Efforts to regulate intoxicating hemp substances in Illinois were shot down this week in what the state’s Governor JB Pritzker called a missed opportunity.
- Uncategorized
New York Legal Cannabis Sales Topped $1bn in 2024 Despite Ongoing Legal Issues
New York’s legal adult-use cannabis market officially surpassed $1bn in annual sales last year, despite regulators ongoing efforts to tackle the flourishing black market.
- Medical
France’s New Health Minister Extends Medical Cannabis Programme Again, But Patients Urged to Seek Alternative Treatment
Thousands of French medical cannabis patients have been given a temporary reprieve, enabling them to continue accessing their treatment for another six months.
- Uncategorized
Hope for Hemp: USDA Nominations and New Initiatives Drive Optimism for Sector in 2025
US hemp regulation was one of the most controversial and potentially impactful debates in 2024, but signs are already emerging that 2025 could be a positive year for the sector.












